Probucol orally administered nanometer solid preparation and preparation method for same
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
- Publication Date
- 2012-05-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the technical field of medical engineering, in particular to a probucol oral nano solid preparation and a preparation method thereof. Background technique
[0002] Probucol, also known as probucol, is the first blood lipid-lowering drug listed in the United States in 1977. Because it lowers high-density lipoprotein cholesterol (HDL) while lowering cholesterol, it fades out of the market. After twenty years of clinical research, it was found that although probucol lowered HDL, not only did atherosclerosis not aggravate, on the contrary probucol showed a strong anti-atherosclerosis effect. In addition, probucol also has powerful anti-oxidation, anti-aging, and treatment of restenosis after angioplasty. Therefore, probucol has once again been valued clinically.
[0003] The main pharmacological effects of probucol include reducing cholesterol synthesis and promoting cholesterol decomposition, changing the properties and functio...